3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
6
Lymphoma, Non-Hodgkin
6
Rhabdoid Tumor
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Medulloblastoma
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Glioma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Osteosarcoma
4
Lymphoma
4
Central Nervous System Neoplasms
4
Sarcoma, Ewing
3
Multiple Myeloma
3
Lung Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroendocrine Tumors
2
Malignant Solid Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Burkitt Lymphoma
2
Xanthogranuloma, Juvenile
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Interventions
Cyclophosphamide
13
Doxorubicin
9
Trastuzumab
8
Taxes
7
Paclitaxel
7
Docetaxel
5
Carboplatin
5
Albumin-Bound Paclitaxel
5
Radiotherapy
4
Epirubicin
4
pertuzumab
3
pembrolizumab
3
Melphalan
3
130-nm albumin-bound paclitaxel
3
eribulin
2
Thiotepa
2
Tamoxifen
2
Peripheral Blood Stem Cell Transplantation
2
Lapatinib
2
Fluorouracil
2
Filgrastim
2
Bevacizumab
2
2C4 antibody
2
trastuzumab biosimilar HLX02
1
talimogene laherparepvec
1
sargramostim
1
ruxolitinib
1
romidepsin
1
pegfilgrastim
1
pazopanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Inflammatory Breast Neoplasms
×
X-Rays
×
Clear all
No trials found.